Cardozo Shaun, Ahmed Tasneem, Belgrave Kevin
Division of Cardiology, Department of Internal Medicine, Detroit Medical Center, Harper University Hospital, Wayne State University, Detroit, MI 48201, USA.
Case Rep Cardiol. 2015;2015:464135. doi: 10.1155/2015/464135. Epub 2015 Jan 27.
The Impella LP 2.5 (Abiomed, Danvers, MA) has been a tool of use for high risk coronary procedures and for cardiogenic shock. As with any invasive or intracardiac device, improper placement can result in disastrous complications. Hemolytic anemia secondary to Impella implantation is one of the documented complications. However, cases of severe hemolytic anemia are rare in the literature. Proven imaging modalities like ultrasound need to be used to guide proper placement. We present a case of device induced severe hemolysis due to Impella insertion and the need to use ultrasound guidance to avoid such an unnecessary complication.
Impella LP 2.5(美国马萨诸塞州丹弗斯市的Abiomed公司生产)一直是高风险冠状动脉手术和心源性休克治疗中使用的一种工具。与任何侵入性或心内装置一样,放置不当可能导致灾难性并发症。Impella植入后继发性溶血性贫血是已记录的并发症之一。然而,文献中严重溶血性贫血的病例很少见。需要使用超声等已证实的成像方式来指导正确放置。我们报告一例因插入Impella导致装置引起的严重溶血病例,以及需要使用超声引导以避免这种不必要并发症的情况。